Proton pump inhibitors in critically ill mechanically ventilated patients with COVID-19: protocol for a substudy of the Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial

BACKGROUND: Critically ill patients commonly receive proton pump inhibitors (PPIs) to prevent gastrointestinal (GI) bleeding from stress-induced ulceration. Despite widespread use in the intensive care unit (ICU), observational data suggest that PPIs may be associated with adverse outcomes in patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Dennis, Brittany B., Thabane, Lehana, Heels-Ansdell, Diane, Dionne, Joanna C., Binnie, Alexandra, Tsang, Jennifer, Guyatt, Gordon, Ahmed, Aijaz, Lauzier, François, Deane, Adam, Arabi, Yaseen, Marshall, John, Zytaruk, Nicole, Saunders, Lois, Finfer, Simon, Myburgh, John, Muscedere, John, English, Shane, Ostermann, Marlies, Hardie, Miranda, Knowles, Serena, Cook, Deborah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466724/
https://www.ncbi.nlm.nih.gov/pubmed/37644556
http://dx.doi.org/10.1186/s13063-023-07589-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466724/
https://www.ncbi.nlm.nih.gov/pubmed/37644556
http://dx.doi.org/10.1186/s13063-023-07589-2

Ejemplares similares